Subcellular Organelle Biogenesis and Dynamics in Peroxisome Proliferation

Abstract

Peroxisome proliferation, a phenomenon studied intensively for the past quarter century is a seemingly uniform reaction of the liver to hypolipidemic drugs and some industrial chemicals. However, application of quantitative microscopic techniques revealed unsuspected characteristics, and facilitated the analysis of peroxisome biogenesis, a dynamic process occurring without disruption of the hepatocyte architecture. The rate of peroxisome biogenesis accelerates to a significant degree within a brief period after compound administration, and the peroxisome population can accumulate up to seven times the normal level. Degradation of peroxisomes follows a triphasic curve and the overall rate of elimination is about the same as the rate of accumulation. Quantitative morphometric studies show interspecies differences in peroxisome induction, with rats being the most susceptible species. Hamsters show peroxisome induction although not to the same substantive extent seen in rats. Monkeys and dogs show poor response, but longer-term data are needed.

References

Alexson, S.E.H. , Fujiki, Y. , Shio, H. , and Lazarow, P.B. (1985). Partial disassembly of peroxisomes. J. Cell Biol. 101:294–304.

De Duve, C. and Baudhuin, P. (1966). Peroxisomes (microbodies and related particles). Physiol. Rev. 46:323–357.

De Duve, C. , Lazarow, P.B. , and Poole, B. (1974). Biogenesis and turnover of rat-liver peroxisomes, in: Advances in Cytopharmacology 2, B. Ceccarelli , F. Clementi , and J. Meldolesi (eds.). Raven Press: New York, pp. 219–223.

Foxworthy, P.S. , White, S.L. , Hoover, D.M. , and Eacho, P.I. (1990). Effect of ciprofibrate, bezafibrate and LY171883 on peroxisomal beta-oxidation in cultured rat, dog, and Rhesus monkey hepatocytes. Toxicol. Appl. Pharmacol. 104:386–394.

Gray, R.H. and De La Iglesia, F.A. (1984). Quantitative microscopy comparison of peroxisome proliferation by the lipid-regulating agent gemfibrozil in several species. Hepatology 4:520–530.

Hess, R. , Stäubli, W. , and Riess, W. (1965). Nature of the hepatomegalic effect produced by ethyl-chlorophenoxyisobu- tyrate in the rat. Nature (London) 208:856–858

Lazarow, P.B. (1983). Catabolic functions of peroxisomes: modification by hypolipidemic drugs. J. Am. Coll. Toxicol. 2:101–109.

Lock, E.A. , Mitchell, A.M. , and Elcombe, C.R. (1989). Biochemical mechanisms of induction of hepatic peroxisome proliferation. Ann. Rev. Pharmacol. Toxicol. 29:145–163.

Loud, A.V. (1968). A quantitative stereological description of the ultrastructure of normal rat liver parenchymal cells. J Cell. Biol. 37:27–46.

10.

Mcguire, E.J. , Lucas, J.A. , Gray, R.H. , and De La Iglesia, F.A. (1991). Peroxisome induction potential and lipid-regulating activity in rats: quantitative microscopy and chemical structure-activity relationships. Am. J. Path. 139:217–229.

11.

Reddy, J.K. , Goel, S.K. , Nemali, M.R. , Carrino, J.J. , and Laffler, T.G. (1986). Transcriptional regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators. Proc. Natl. Acad. Sci. (USA) 83:1747–1751.

12.

Reddy, J.K. and Lalwani, N.D. (1984). Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit. Rev. Toxicol. 12:1–58.

13.

Rodricks, J.V. and Turnbull, D. (1987). Interspecies differences in peroxisomes and peroxisome proliferation. Toxicol. Ind. Health 3:197–213.

14.

Schulte-Hermann, R. (1974). Induction of liver growth by xenobiotic compounds and other stimuli. CRC Crit. Rev. Toxicol. 3:97–158.